Skip to content

Clinical trials

Withdrawn Phase 2 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Status: Withdrawn Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20051
20071
20081
20131
20153
20162
20183
20191
20203
20213
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota2
City of Hope Medical Center1
Cornerstone Pharmaceuticals1
European Organisation for Research and Treatment of Cancer - EORTC1
European Society for Blood and Marrow Transplantation1
Fondazione Italiana Sindromi Mielodisplastiche-ETS1
Fred Hutchinson Cancer Center1
Fujifilm Pharmaceuticals U.S.A., Inc.1
Hadassah Medical Organization1
Haukeland University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes31
Leukemia, Myeloid, Acute13
Primary Myelofibrosis5
Hodgkin Disease4
Leukemia4
Leukemia, Myeloid, Chronic-Phase4
Leukemia, Myelomonocytic, Chronic4
Lymphoma, Non-Hodgkin4
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.